Indo Us Biotech Limited announced on December 29, 2025, that it has received a summons dated November 20, 2025, from the Directorate of Enforcement (ED), Raipur Zonal Office. The summons was issued under Section 50(2) and 50(3) of the Prevention of Money Laundering Act (PMLA), 2002, requiring the appearance of the Principal Officer and the production of specific information and documents for investigation purposes. The company received the summons via mail on November 27, 2025. The ED has not passed any formal charges or orders, and the summons is for inquiry and investigative purposes. Indo Us Biotech Limited stated that there is no immediate material impact on the financial or operational activities of the Company. The delay in disclosure was attributed to the time taken for internal review of the summons and awaiting legal assessment to ensure the accuracy of the disclosure, with the company assuring that the delay was not intentional.